Pichín QA, Franco MMC, Díaz HD, Sancho SAN, Pages GO

Language: Spanish
References: 8
Page: 422-426
PDF size: 78.89 Kb.

ABSTRACT

The case report of a 36 years patient who attended the department to ask for a tattoo removal in the most possible aesthetic way, that he had in the right shoulder for more than 5 years is presented. Once the surgical exeresis of this tattoo was carried out, 6 sections of Heberprot-P^® were applied as alternative method of treatment. After 12 days, a total scaring had already been obtained, there were no adverse reactions and the patient was completely satisfied with the used medication.

REFERENCES

1. Sierra Valenti X. Tatuajes. Un estudio antropológico y social. Piel. 2009; 24(6): 314-24.

2. Boulton AJ, Vileikyte L, Ragnarson Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005; 366 (9498):1719-24.

3. Veves A, Gurini J. The diabetic Foot. 2ed. Boston: Humana Press; 2006.

4. Prats PA, Castañeda LO, Falcón V, Ortega R, de la Rosa MC, Menéndez I, Labarta V, Gómez R. Efecto del factor de crecimiento epidérmico sobre la regeneración del nervio ciático transectado en ratas. Biotecnología aplicada. 1998;15(2):237-41.

5. Quiñones M, Mc Cook J, Zacca E, Martinez MA. Efecto del factor de crecimiento epidérmico humano recombinante en las úlceras de los miembros inferiores causadas por insuficiencia venosa crónica. Progreso en Ciencias Médicas. 1991. 10(1):11-4.

6. Man WT, Wan KR, Chi ST, Kwork Man L, Wegin T, Elaine YN C, et al. Human epidermal growth factor enhances healing of diabetic foot Ulcers. Diabetic Car. 2003;26(6):1856-61.

7. Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers . Ann Plast Surg. 2006;56(4):394- 400.

8. Organización Mundial de la Salud. La farmacovigilancia: garantía de seguridad en el uso de los medicamentos. Ginebra: OMS;